Cardio Diagnostics Holdings (CDIO) Retained Earnings (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Retained Earnings of -$31.0 million for Q1 2026, down 185.69% sequentially from $36.2 million in Q4 2025, and down 27.27% YoY from -$42.7 million in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Retained Earnings (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Retained Earnings for 6 years, with the latest figure at -$31.0 million in Q1 2026.
- Quarterly Retained Earnings fell 27.27% year-over-year to -$31.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.0 million (down 27.27% YoY) and the FY2025 annual result came in at $36.2 million, up 259.21% from the prior year.
- Retained Earnings declined to -$31.0 million in Q1 2026 per CDIO's latest filing, from $36.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $36.2 million in Q4 2025 and troughed at -$31.0 million in Q1 2026.
- A 5-year average of $4.7 million and a median of $10.3 million in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 2942.5% in 2023, down 1434.91% in 2023.
- Over 5 years, Retained Earnings stood at $10.3 million in 2022, then soared by 68.33% to $17.3 million in 2023, then slumped by 231.31% to -$22.8 million in 2024, then surged by 259.21% to $36.2 million in 2025, then slumped by 185.69% to -$31.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$31.0 million, $36.2 million, and $35.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Cardio Diagnostics Holdings | 6.05 Mn | 460,682.10 | - | 39.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.97 Mn |
| Mar 31, 2026 | -31.04 Mn |
| Dec 31, 2025 | 36.22 Mn |
| Sep 30, 2025 | 35.94 Mn |
| Jun 30, 2025 | -26.07 Mn |
| Mar 31, 2025 | -24.39 Mn |
| Dec 31, 2024 | -22.75 Mn |
| Sep 30, 2024 | 24.92 Mn |
| Jun 30, 2024 | 22.89 Mn |
| Mar 31, 2024 | 21.57 Mn |
| Dec 31, 2023 | 17.33 Mn |
| Sep 30, 2023 | 15.27 Mn |
| Jun 30, 2023 | -11.05 Mn |
| Mar 31, 2023 | 10.45 Mn |
| Dec 31, 2022 | 10.29 Mn |
| Sep 30, 2022 | -747,931.00 |
| Jun 30, 2022 | 827,553.00 |
| Mar 31, 2022 | -367,500.00 |
| Dec 31, 2021 | -1.33 Mn |